Free Trial

Curaleaf (OTCMKTS:CURLF) Hits New 12-Month Low - Time to Sell?

Curaleaf logo with Medical background
Remove Ads

Curaleaf Holdings, Inc. (OTCMKTS:CURLF - Get Free Report) shares reached a new 52-week low on Tuesday . The company traded as low as $0.87 and last traded at $0.89, with a volume of 534912 shares. The stock had previously closed at $0.91.

Curaleaf Trading Up 0.7 %

The company has a 50 day moving average price of $1.24 and a 200 day moving average price of $1.93. The firm has a market cap of $660.74 million, a price-to-earnings ratio of -3.45 and a beta of 0.57. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.51 and a current ratio of 1.11.

Curaleaf (OTCMKTS:CURLF - Get Free Report) last issued its quarterly earnings results on Monday, March 3rd. The company reported $0.02 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.07) by $0.09. The business had revenue of $331.05 million for the quarter, compared to analyst estimates of $331.87 million. Curaleaf had a negative net margin of 14.82% and a negative return on equity of 13.67%. On average, research analysts expect that Curaleaf Holdings, Inc. will post -0.25 earnings per share for the current year.

Curaleaf Company Profile

(Get Free Report)

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.

Featured Articles

Should You Invest $1,000 in Curaleaf Right Now?

Before you consider Curaleaf, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Curaleaf wasn't on the list.

While Curaleaf currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

These 3 Dividend Stocks Might Be the Safest Bet Right Now
5 International Stocks to Escape U.S. Market Volatility
MicroStrategy’s Bold Bitcoin Bet: Genius Move or Dangerous Gamble?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads